• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Resmed Inc (NY: RMD )

    242.69 +0.44 (+0.18%)
    Official Closing Price Updated: 7:00 PM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,226,788
    Open 240.54
    Bid (Size) 238.97 (2)
    Ask (Size) 242.50 (4)
    Prev. Close 242.25
    Today's Range 239.37 - 246.80
    52wk Range 132.24 - 246.80
    Shares Outstanding 146,234,244
    Dividend Yield 0.79%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From ResMed Inc.
    Via GlobeNewswire
    How Is The Market Feeling About ResMed?
    Via Benzinga

    Performance

    YTD
    +41.28%
    +41.28%
    1 Month
    +16.38%
    +16.38%
    3 Month
    +17.83%
    +17.83%
    6 Month
    +39.51%
    +39.51%
    1 Year
    +48.04%
    +48.04%

    More News

    Read More
    $1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
    Via Benzinga
    RxSight Stock Sees Relative Strength Rating Rise To 91
    Via Investor's Business Daily
    Why Quality-Oriented Investors Should Consider NYSE:RMD.
    Via Chartmill
    NYSE:RMD may be ready to breakout.
    Via Chartmill
    Uncovering Dividend Opportunities with NYSE:RMD.
    Via Chartmill
    If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
    Via Benzinga
    ResMed's Options Frenzy: What You Need to Know
    Via Benzinga
    ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
    From ResMed Inc.
    Via GlobeNewswire
    DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
    Via Benzinga
    ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
    Via Benzinga
    If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
    Via Benzinga
    What 6 Analyst Ratings Have To Say About ResMed
    Via Benzinga
    Looking Into ResMed's Recent Short Interest
    Via Benzinga
    ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
    From ResMed Inc.
    Via GlobeNewswire
    Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Stock Market News From Amazon, Nike, McCormick, and More
    Via The Motley Fool
    Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts
    Via InvestorPlace
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today
    Via Benzinga
    Is NYSE:RMD a Good Fit for Dividend Investing?
    Via Chartmill
    ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
    From ResMed Inc.
    Via GlobeNewswire
    How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
    Via The Motley Fool
    Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
    Via MarketBeat
    Exposures Product Safety
    Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.